| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Isotretinoin | FAERS: 3 | US FAERS | |
| 2 | Imatinib Mesylate | FAERS: 2 | US FAERS | |
| 3 | Thalidomide | FAERS: 2 | US FAERS | |
| 4 | Alendronate | FAERS: 1 | US FAERS | |
| 5 | Diclofenac | FAERS: 1 | US FAERS | |
| 6 | Esomeprazole | FAERS: 1 | US FAERS | |
| 7 | HhAntag691 | FAERS: 1 | US FAERS | |
| 8 | Lenalidomide | FAERS: 1 | OFFSIDES US FAERS | |
| 9 | Mesalamine | FAERS: 1 | US FAERS | |
| 10 | Morphine | FAERS: 1 | US FAERS | |
| 11 | Omeprazole | FAERS: 1 | US FAERS | |
| 12 | Teriparatide | FAERS: 1 | US FAERS | |
| 13 | tofacitinib | FAERS: 1 | US FAERS | |
| 14 | Bosentan | Canada Vigilance: 1 | Canada Vigilance | |
| 15 | Octreotide | Canada Vigilance: 1 | Canada Vigilance | |
| 16 | Perindopril | OFFSIDES | ||
| 17 | Propofol | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.